» Articles » PMID: 38191761

[Histopathologic Diagnosis of Solid and Cystic Pancreatic Lesions with a Focus on Ductal Adenocarcinoma : A Vademecum for Daily Practice]

Overview
Specialty Pathology
Date 2024 Jan 8
PMID 38191761
Authors
Affiliations
Soon will be listed here.
Abstract

Pancreas pathology is constantly evolving and can present various challenges for pathologists. This paper is focused on providing helpful hints for daily routine diagnostics. During histopathological analysis of pancreas biopsies, pancreatic ductal adenocarcinoma must be distinguished not only from other solid neoplasms, but especially from its mimicker, autoimmune pancreatitis. This can be achieved by a systematic workup following clear diagnostic criteria. When analyzing samples from cystic pancreatic lesions, mucin-producing neoplasms must be detected due to their role as pancreatic cancer precursors; molecular analyses can help considerably with their detection and distinction. During frozen section examination, evaluation of the pancreatic neck margin and analysis of unclear lesions of the liver are two important tasks, which are explained further in this article. A special challenge is the evaluation of neoadjuvant treated pancreatic cancer, which requires a detailed macroscopic and microscopic workup. Finally, current advances in precision oncology and emerging approaches for pancreatic cancer within this field are discussed. With the advancement of technical possibilities and their increasingly broad implementation, the classification systems in pancreatic pathology will continue to gain in complexity, but also in accuracy.

References
1.
Agaimy A, Haller F, Frohnauer J, Schaefer I, Strobel P, Hartmann A . Pancreatic undifferentiated rhabdoid carcinoma: KRAS alterations and SMARCB1 expression status define two subtypes. Mod Pathol. 2014; 28(2):248-60. DOI: 10.1038/modpathol.2014.100. View

2.
Barthel S, Falcomata C, Rad R, Theis F, Saur D . Single-cell profiling to explore pancreatic cancer heterogeneity, plasticity and response to therapy. Nat Cancer. 2023; 4(4):454-467. PMC: 7615362. DOI: 10.1038/s43018-023-00526-x. View

3.
Bazzichetto C, Luchini C, Conciatori F, Vaccaro V, Di Cello I, Mattiolo P . Morphologic and Molecular Landscape of Pancreatic Cancer Variants as the Basis of New Therapeutic Strategies for Precision Oncology. Int J Mol Sci. 2020; 21(22). PMC: 7700259. DOI: 10.3390/ijms21228841. View

4.
Chatterjee D, Katz M, Foo W, Sundar M, Wang H, Varadhachary G . Prognostic Significance of New AJCC Tumor Stage in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant Therapy. Am J Surg Pathol. 2017; 41(8):1097-1104. PMC: 5527751. DOI: 10.1097/PAS.0000000000000887. View

5.
Cheng B, Zhang Y, Chen Q, Sun B, Deng Z, Shan H . Analysis of Fine-Needle Biopsy vs Fine-Needle Aspiration in Diagnosis of Pancreatic and Abdominal Masses: A Prospective, Multicenter, Randomized Controlled Trial. Clin Gastroenterol Hepatol. 2017; 16(8):1314-1321. DOI: 10.1016/j.cgh.2017.07.010. View